Holy Name Medical Center

Teaneck, New Jersey 07666

8 studies enrolling now · 89 studies all time

What they study most

ALI, ARDS, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Acute Myocardial Infarction (AMI), Advanced Non Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, Angina Pectoris, Appendiceal Cancer, Arteriovenous Fistula, Arteriovenous Fistula Occlusion, Arteriovenous Fistula Stenosis, Artery Disease, Peripheral

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer — Recruiting now
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised — Recruiting now
• DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis — Recruiting now
• REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants — Recruiting now
• A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events — Recruiting now
• MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study — Recruiting now
• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. — Recruiting now
• Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer — Recruiting now
• PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study — Recruiting now
• Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery — Completed
• Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• MOTIV BTK Randomized Controlled Trial — Running, not enrolling
• A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL) — Completed
• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• Abemaciclib and Letrozole to Treat Endometrial Cancer — Running, not enrolling
• Aventus Thrombectomy System Pulmonary Embolism Clinical Study — Running, not enrolling
• SELUTION4SFA Trial — Running, not enrolling
• LIFE-BTK Randomized Controlled Trial — Running, not enrolling
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) — Running, not enrolling
• IN.PACT™ AV Access Post-Approval Study (PAS002) — Running, not enrolling
• Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19 — Completed
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis — Stopped early
• Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System — Completed
• Safety and Efficacy of the SurVeil™ Drug-Coated Balloon — Completed
• Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection — Stopped early
• Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation — Running, not enrolling
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression — Completed
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• IN.PACT™ AV Access IDE Study — Completed
• Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults — Stopped early
• Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
• Complete Lesion Assessment With ffR and IVUS TechnologY — Completed
• Acquired Methemoglobinemia Observational Registry — Completed
• Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia — Completed
• Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 — Stopped early
• ABRE Clinical Study of the Abre Venous Self-expanding Stent System — Completed